2024. The 40-gene Expression Profile (40-GEP) Test Identifies Cutaneous Squamous Cell Carcinoma (cSCC) Patients at High Risk of Metastasis within Lower-Staged Tumors to Better Guide Treatment Decisions. SKIN The Journal of Cutaneous Medicine. 8, 2 (Mar. 2024), s385. DOI:https://doi.org/10.25251/skin.8.supp.385.